Daiichi Sankyo Co Ltd (4568.T)
Latest Key Developments (Source: Significant Developments)
July 21 (Reuters) - EU Medicines Agency: :EU Medicines Agency recommendations For July 2017.EU Medicines Agency recommends approval of Pfizer Inc and Merck KGAA Avelumab drug for cell carcinoma.EU Medicines Agency recommends approval of Sanofi and Regeneron Dupixent drug for severe eczema.EU Medicines Agency recommends approval Of Roche Tecentriq drug for drug for bladder and lung cancer.EU Medicines Agency recommends approval Of Advanced Accelerator Applications Lutathera drug for gastroenteropancreatic neuroendocrine tumours.EU Medicines Agency recommends against approval of Nektar Therapeutics and Daiichi Sankyo Onzeald drug for breast cancer.EU Medicines Agency recommends approval of Novartis Rydapt drug for leukaemia. Full Article
July 4 (Reuters) - HansolNexG Co Ltd <081970.KQ> ::* Says C&Kim Co Ltd has acquired 613,100 shares of the co, and is holding 10.6 percent stake in the co, from 0 percent stake . Full Article
Daiichi Sankyo announces top-line results from phase 3 global clinical development program evaluating mirogabalin in pain syndromes
June 30 (Reuters) - Daiichi Sankyo Co Ltd <4568.T>:Daiichi Sankyo announces top-line results from phase 3 global clinical development program evaluating mirogabalin in pain syndromes.Daiichi Sankyo Co Ltd - Preliminary and ongoing analyses indicated no unexpected safety concerns in neucourse or alday clinical trials.Daiichi Sankyo Co Ltd - In phase 3 alday clinical trials, mirogabalin did not meet primary efficacy endpoint.Says in neucourse, mirogabalin met primary efficacy endpoint. Full Article
May 25 (Reuters) - Nikkei::Daiichi Sankyo to invest 22 billion yen in U.S. for Luitpold Pharmaceuticals; targets about 70 pct rise in Luitpold's sales to 150 billion yen in fiscal 2020 versus 2015 - Nikkei. Full Article
April 27 (Reuters) - Daiichi Sankyo Co Ltd <4568.T>::Daiichi Sankyo - making initial 15 billion yen investment to optimize and enhance manufacturing capabilities to support growing antibody drug conjugate pipeline. Full Article
April 18 (Reuters) - GlaxoSmithKline Plc
April 17 (Reuters) - Htg Molecular Diagnostics Inc
Sosei Group unit signs alliance for R & D of new small molecule therapeutic drug with DAIICHI SANKYO COMPANY LIMITED.
Sosei Group Corp <4565.T>:Says its subsidiary Heptares signed an alliance for R & D of new small molecule therapeutic drug with DAIICHI SANKYO COMPANY LIMITED. on March 13. Full Article
Amring Pharmaceuticals Inc : Amring pharmaceuticals inc - acquired six andas from luitpold pharmaceuticals inc and alphaforce l.l.p. .Amring pharmaceuticals inc - acquired andas include niche otic and ophthalmic pharmaceuticals. Full Article
EU Medicines Agency: EU medicines Agency recommendations for February 2017 . EU Medicines Agency recommends approval Of Daiichi Sankyo's anticoagulant Edoxaban . EU Medicines Agency says adopted positive opinion recommending changes to the terms of the marketing authorisation for the medicinal product Darzalex . EU Medicines Agency recommends approval of Hospira UK Limited's Pemetrexed for treatment of non-small cell lung cancer Source (http://bit.ly/2lCHPks) Further company coverage: [4568.T] ((Bangalore.firstname.lastname@example.org;)). Full Article
European regulators on Friday recommended against granting approval to a breast cancer drug being developed by Nektar Therapeutics and Daiichi Sankyo's German unit.